| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4030407 | Ophthalmology | 2006 | 7 Pages |
Abstract
Treatment with immunosuppressive drugs may improve VA outcomes among patients with MFCPU by reducing the risk of sight-threatening posterior pole complications, including new-onset choroidal neovascularization and recurrent choroidal neovascularization among eyes with existing choroidal neovascularization.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jennifer E. MD, PhD, Susan MD, Douglas A. MD, MBA, George B. MD, MBA, Terry L. COA, Sanjay R. MD, James P. MD,